MedTrace Logo

Early Versus Delayed Cord Clamping at Term: Outcomes in Swedish Infants

NCT01245296 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 392

Last updated 2014-08-20

No results posted yet for this study

Summary

Delayed clamping of the umbilical cord might prevent or slow the onset of iron deficiency by increasing the infant's iron endowment at birth. Compared with early clamping, a delay of around 2-3 min provides an additional 25-40 mL of blood per kg of bodyweight.

The results of previous intervention studies on delayed clamping are mixed, and few followed up infants beyond the perinatal period. All longer follow up studies have been performed in low income countries. The main objectives, therefore, was to assess whether delayed cord clamping improves hematological and iron status at 4 respective 12 months of age in a large sample of full-term, Swedish infants.

The investigators also choose to investigate if the timing of clamping the umbilical cord could affect rate of infections during the first four months of life and to assess the infants development at 4 and 12 months of age.

Conditions

Interventions

PROCEDURE

Timing of clamping the umbilical cord

The time passed after delivery until that the midwife stops circulation in the umbilical cord with a clamp.

Sponsors & Collaborators

  • Umeå University

    collaborator OTHER

  • Halmstad County Hospital

    collaborator OTHER

  • County Council of Halland, Sweden

    collaborator OTHER_GOV

  • Uppsala University

    lead OTHER

Principal Investigators

  • Ola Andersson, M.D. · Uppsala University

  • Magnus Domellöf, MD, PhD · Umeå University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
37 Weeks
Max Age
42 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01245296 on ClinicalTrials.gov